Project
Illumina Body Map 2
Navigation
Downloads
Results for FLI1
Z-value: 1.82
Motif logo
Transcription factors associated with FLI1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
FLI1
|
ENSG00000151702.12 | Fli-1 proto-oncogene, ETS transcription factor |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| FLI1 | hg19_v2_chr11_+_128634589_128634685 | 0.92 | 8.7e-14 | Click! |
Activity profile of FLI1 motif
Sorted Z-values of FLI1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr1_-_161039456 | 6.62 |
ENST00000368016.3
|
ARHGAP30
|
Rho GTPase activating protein 30 |
| chr3_+_108541545 | 6.46 |
ENST00000295756.6
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
| chr3_+_108541608 | 6.08 |
ENST00000426646.1
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
| chr10_-_72362515 | 6.05 |
ENST00000373209.2
ENST00000441259.1 |
PRF1
|
perforin 1 (pore forming protein) |
| chr22_+_23165153 | 5.76 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
| chr1_+_32716840 | 5.45 |
ENST00000336890.5
|
LCK
|
lymphocyte-specific protein tyrosine kinase |
| chr14_+_88471468 | 5.40 |
ENST00000267549.3
|
GPR65
|
G protein-coupled receptor 65 |
| chr1_+_32716857 | 5.33 |
ENST00000482949.1
ENST00000495610.2 |
LCK
|
lymphocyte-specific protein tyrosine kinase |
| chr1_-_167059830 | 5.13 |
ENST00000367868.3
|
GPA33
|
glycoprotein A33 (transmembrane) |
| chr3_-_183273477 | 5.08 |
ENST00000341319.3
|
KLHL6
|
kelch-like family member 6 |
| chr19_+_3178736 | 5.07 |
ENST00000246115.3
|
S1PR4
|
sphingosine-1-phosphate receptor 4 |
| chr4_+_153021899 | 5.01 |
ENST00000509332.1
ENST00000504144.1 ENST00000499452.2 |
RP11-18H21.1
|
RP11-18H21.1 |
| chr11_+_60223312 | 4.94 |
ENST00000532491.1
ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
| chr17_+_38673270 | 4.81 |
ENST00000578280.1
|
RP5-1028K7.2
|
RP5-1028K7.2 |
| chr19_+_42381173 | 4.78 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
| chr15_+_81589254 | 4.76 |
ENST00000394652.2
|
IL16
|
interleukin 16 |
| chr1_-_161039647 | 4.69 |
ENST00000368013.3
|
ARHGAP30
|
Rho GTPase activating protein 30 |
| chr8_-_133772794 | 4.53 |
ENST00000519187.1
ENST00000523829.1 ENST00000356838.3 ENST00000377901.4 ENST00000519304.1 |
TMEM71
|
transmembrane protein 71 |
| chr14_+_22475742 | 4.47 |
ENST00000390447.3
|
TRAV19
|
T cell receptor alpha variable 19 |
| chr11_+_60223225 | 4.45 |
ENST00000524807.1
ENST00000345732.4 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
| chr6_-_31550192 | 4.42 |
ENST00000429299.2
ENST00000446745.2 |
LTB
|
lymphotoxin beta (TNF superfamily, member 3) |
| chr22_+_27068704 | 4.37 |
ENST00000444388.1
ENST00000450963.1 ENST00000449017.1 |
CTA-211A9.5
|
CTA-211A9.5 |
| chr6_+_31553901 | 4.32 |
ENST00000418507.2
ENST00000438075.2 ENST00000376100.3 ENST00000376111.4 |
LST1
|
leukocyte specific transcript 1 |
| chr19_+_42381337 | 4.21 |
ENST00000597454.1
ENST00000444740.2 |
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
| chr16_+_32859034 | 4.14 |
ENST00000567458.2
ENST00000560724.1 |
IGHV2OR16-5
|
immunoglobulin heavy variable 2/OR16-5 (non-functional) |
| chr14_-_106114739 | 4.11 |
ENST00000460164.1
|
RP11-731F5.2
|
RP11-731F5.2 |
| chr14_-_106406090 | 4.10 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
| chr11_+_118175596 | 4.09 |
ENST00000528600.1
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex) |
| chr14_+_22520762 | 3.92 |
ENST00000390449.3
|
TRAV21
|
T cell receptor alpha variable 21 |
| chr11_-_67205538 | 3.88 |
ENST00000326294.3
|
PTPRCAP
|
protein tyrosine phosphatase, receptor type, C-associated protein |
| chr10_-_81320151 | 3.84 |
ENST00000372325.2
ENST00000372327.5 ENST00000417041.1 |
SFTPA2
|
surfactant protein A2 |
| chr8_-_133772870 | 3.83 |
ENST00000522334.1
ENST00000519016.1 |
TMEM71
|
transmembrane protein 71 |
| chr16_+_28996114 | 3.82 |
ENST00000395461.3
|
LAT
|
linker for activation of T cells |
| chr1_-_153518270 | 3.81 |
ENST00000354332.4
ENST00000368716.4 |
S100A4
|
S100 calcium binding protein A4 |
| chr11_+_118175132 | 3.75 |
ENST00000361763.4
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex) |
| chr10_+_81370689 | 3.75 |
ENST00000372308.3
ENST00000398636.3 ENST00000428376.2 ENST00000372313.5 ENST00000419470.2 ENST00000429958.1 ENST00000439264.1 |
SFTPA1
|
surfactant protein A1 |
| chr16_+_28996416 | 3.75 |
ENST00000395456.2
ENST00000454369.2 |
LAT
|
linker for activation of T cells |
| chr14_-_106830057 | 3.75 |
ENST00000390616.2
|
IGHV4-34
|
immunoglobulin heavy variable 4-34 |
| chr22_+_27068766 | 3.73 |
ENST00000435162.1
ENST00000437071.1 ENST00000440816.1 ENST00000421253.1 |
CTA-211A9.5
|
CTA-211A9.5 |
| chr14_-_107083690 | 3.67 |
ENST00000455737.1
ENST00000390629.2 |
IGHV4-59
|
immunoglobulin heavy variable 4-59 |
| chr14_+_22392209 | 3.60 |
ENST00000390440.2
|
TRAV14DV4
|
T cell receptor alpha variable 14/delta variable 4 |
| chr14_-_106878083 | 3.59 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
| chr6_+_31553978 | 3.57 |
ENST00000376096.1
ENST00000376099.1 ENST00000376110.3 |
LST1
|
leukocyte specific transcript 1 |
| chr16_+_28996572 | 3.51 |
ENST00000360872.5
ENST00000566177.1 ENST00000354453.4 |
LAT
|
linker for activation of T cells |
| chr14_-_107095662 | 3.48 |
ENST00000390630.2
|
IGHV4-61
|
immunoglobulin heavy variable 4-61 |
| chr16_+_28996364 | 3.48 |
ENST00000564277.1
|
LAT
|
linker for activation of T cells |
| chr14_+_22573582 | 3.38 |
ENST00000390453.1
|
TRAV24
|
T cell receptor alpha variable 24 |
| chr16_+_30484054 | 3.37 |
ENST00000564118.1
ENST00000454514.2 ENST00000433423.2 |
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
| chr21_+_43823983 | 3.37 |
ENST00000291535.6
ENST00000450356.1 ENST00000319294.6 ENST00000398367.1 |
UBASH3A
|
ubiquitin associated and SH3 domain containing A |
| chr1_-_160616804 | 3.35 |
ENST00000538290.1
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1 |
| chr6_-_32784687 | 3.34 |
ENST00000447394.1
ENST00000438763.2 |
HLA-DOB
|
major histocompatibility complex, class II, DO beta |
| chr14_-_106478603 | 3.32 |
ENST00000390596.2
|
IGHV4-4
|
immunoglobulin heavy variable 4-4 |
| chr1_+_209929494 | 3.30 |
ENST00000367026.3
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
| chrX_-_70331298 | 3.29 |
ENST00000456850.2
ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG
|
interleukin 2 receptor, gamma |
| chr7_+_50348268 | 3.26 |
ENST00000438033.1
ENST00000439701.1 |
IKZF1
|
IKAROS family zinc finger 1 (Ikaros) |
| chr1_+_203734296 | 3.26 |
ENST00000442561.2
ENST00000367217.5 |
LAX1
|
lymphocyte transmembrane adaptor 1 |
| chr14_+_22409308 | 3.23 |
ENST00000390441.2
|
TRAV9-2
|
T cell receptor alpha variable 9-2 |
| chr17_+_7239904 | 3.22 |
ENST00000575425.1
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
| chr22_-_37545972 | 3.19 |
ENST00000216223.5
|
IL2RB
|
interleukin 2 receptor, beta |
| chr8_-_21771214 | 3.13 |
ENST00000276420.4
|
DOK2
|
docking protein 2, 56kDa |
| chr1_+_209929377 | 3.12 |
ENST00000400959.3
ENST00000367025.3 |
TRAF3IP3
|
TRAF3 interacting protein 3 |
| chr5_+_133451254 | 3.11 |
ENST00000517851.1
ENST00000521639.1 ENST00000522375.1 ENST00000378560.4 ENST00000432532.2 ENST00000520958.1 ENST00000518915.1 ENST00000395023.1 |
TCF7
|
transcription factor 7 (T-cell specific, HMG-box) |
| chr1_-_161039753 | 3.09 |
ENST00000368015.1
|
ARHGAP30
|
Rho GTPase activating protein 30 |
| chr4_+_40198527 | 3.05 |
ENST00000381799.5
|
RHOH
|
ras homolog family member H |
| chr3_-_112218378 | 3.05 |
ENST00000334529.5
|
BTLA
|
B and T lymphocyte associated |
| chrX_+_128913906 | 3.03 |
ENST00000356892.3
|
SASH3
|
SAM and SH3 domain containing 3 |
| chr12_+_10460549 | 3.00 |
ENST00000543420.1
ENST00000543777.1 |
KLRD1
|
killer cell lectin-like receptor subfamily D, member 1 |
| chr5_-_138861926 | 2.99 |
ENST00000510817.1
|
TMEM173
|
transmembrane protein 173 |
| chr11_+_65647280 | 2.98 |
ENST00000307886.3
ENST00000528419.1 ENST00000526034.1 |
CTSW
|
cathepsin W |
| chr1_-_92952433 | 2.96 |
ENST00000294702.5
|
GFI1
|
growth factor independent 1 transcription repressor |
| chr14_-_106586656 | 2.94 |
ENST00000390602.2
|
IGHV3-13
|
immunoglobulin heavy variable 3-13 |
| chr16_+_32063311 | 2.94 |
ENST00000426099.1
|
AC142381.1
|
AC142381.1 |
| chr11_-_118083600 | 2.92 |
ENST00000524477.1
|
AMICA1
|
adhesion molecule, interacts with CXADR antigen 1 |
| chr5_-_138862326 | 2.90 |
ENST00000330794.4
|
TMEM173
|
transmembrane protein 173 |
| chr16_+_30484021 | 2.86 |
ENST00000358164.5
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
| chr7_-_3083573 | 2.85 |
ENST00000396946.4
|
CARD11
|
caspase recruitment domain family, member 11 |
| chr22_-_17680472 | 2.85 |
ENST00000330232.4
|
CECR1
|
cat eye syndrome chromosome region, candidate 1 |
| chr2_+_89999259 | 2.84 |
ENST00000558026.1
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
| chr1_+_209941827 | 2.79 |
ENST00000367023.1
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
| chr16_+_30483962 | 2.79 |
ENST00000356798.6
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
| chr15_-_22473353 | 2.79 |
ENST00000557788.2
|
IGHV4OR15-8
|
immunoglobulin heavy variable 4/OR15-8 (non-functional) |
| chr22_+_23077065 | 2.77 |
ENST00000390310.2
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
| chr14_-_100842588 | 2.77 |
ENST00000556645.1
ENST00000556209.1 ENST00000556504.1 ENST00000556435.1 ENST00000554772.1 ENST00000553581.1 ENST00000553769.2 ENST00000554605.1 ENST00000557722.1 ENST00000553413.1 ENST00000553524.1 ENST00000358655.4 |
WARS
|
tryptophanyl-tRNA synthetase |
| chr1_+_32739733 | 2.77 |
ENST00000333070.4
|
LCK
|
lymphocyte-specific protein tyrosine kinase |
| chr4_+_102711764 | 2.76 |
ENST00000322953.4
ENST00000428908.1 |
BANK1
|
B-cell scaffold protein with ankyrin repeats 1 |
| chr17_+_4336955 | 2.76 |
ENST00000355530.2
|
SPNS3
|
spinster homolog 3 (Drosophila) |
| chr14_-_107114267 | 2.76 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
| chr12_-_53601055 | 2.75 |
ENST00000552972.1
ENST00000422257.3 ENST00000267082.5 |
ITGB7
|
integrin, beta 7 |
| chr14_+_22748980 | 2.73 |
ENST00000390465.2
|
TRAV38-2DV8
|
T cell receptor alpha variable 38-2/delta variable 8 |
| chr1_+_32739714 | 2.71 |
ENST00000461712.2
ENST00000373562.3 ENST00000477031.2 ENST00000373557.2 |
LCK
|
lymphocyte-specific protein tyrosine kinase |
| chr1_+_209941942 | 2.71 |
ENST00000487271.1
ENST00000477431.1 |
TRAF3IP3
|
TRAF3 interacting protein 3 |
| chr5_+_35856951 | 2.69 |
ENST00000303115.3
ENST00000343305.4 ENST00000506850.1 ENST00000511982.1 |
IL7R
|
interleukin 7 receptor |
| chr10_+_129785536 | 2.67 |
ENST00000419012.2
|
PTPRE
|
protein tyrosine phosphatase, receptor type, E |
| chr19_+_36393422 | 2.67 |
ENST00000437550.2
|
HCST
|
hematopoietic cell signal transducer |
| chr1_+_209929446 | 2.60 |
ENST00000479796.1
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
| chr1_+_153330322 | 2.56 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
| chr7_-_3083472 | 2.55 |
ENST00000356408.3
|
CARD11
|
caspase recruitment domain family, member 11 |
| chr22_+_23101182 | 2.55 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
| chr2_-_235405168 | 2.55 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
| chr21_-_46340807 | 2.55 |
ENST00000397846.3
ENST00000524251.1 ENST00000522688.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr1_-_153517473 | 2.52 |
ENST00000368715.1
|
S100A4
|
S100 calcium binding protein A4 |
| chr4_+_102711874 | 2.52 |
ENST00000508653.1
|
BANK1
|
B-cell scaffold protein with ankyrin repeats 1 |
| chr2_+_202122826 | 2.51 |
ENST00000413726.1
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase |
| chr6_-_133084580 | 2.51 |
ENST00000525270.1
ENST00000530536.1 ENST00000524919.1 |
VNN2
|
vanin 2 |
| chr17_-_33864772 | 2.50 |
ENST00000361112.4
|
SLFN12L
|
schlafen family member 12-like |
| chr17_+_4337199 | 2.49 |
ENST00000333476.2
|
SPNS3
|
spinster homolog 3 (Drosophila) |
| chr12_-_57871620 | 2.44 |
ENST00000552604.1
|
ARHGAP9
|
Rho GTPase activating protein 9 |
| chr17_-_61777090 | 2.41 |
ENST00000578061.1
|
LIMD2
|
LIM domain containing 2 |
| chr6_-_41122063 | 2.40 |
ENST00000426005.2
ENST00000437044.2 ENST00000373127.4 |
TREML1
|
triggering receptor expressed on myeloid cells-like 1 |
| chr19_+_36393367 | 2.39 |
ENST00000246551.4
|
HCST
|
hematopoietic cell signal transducer |
| chr2_+_7865923 | 2.39 |
ENST00000417930.1
|
AC092580.4
|
AC092580.4 |
| chr4_-_48082192 | 2.38 |
ENST00000507351.1
|
TXK
|
TXK tyrosine kinase |
| chr7_-_38398721 | 2.37 |
ENST00000390346.2
|
TRGV3
|
T cell receptor gamma variable 3 |
| chr12_-_57871567 | 2.36 |
ENST00000551452.1
|
ARHGAP9
|
Rho GTPase activating protein 9 |
| chr5_+_96211643 | 2.35 |
ENST00000437043.3
ENST00000510373.1 |
ERAP2
|
endoplasmic reticulum aminopeptidase 2 |
| chr19_-_10446449 | 2.34 |
ENST00000592439.1
|
ICAM3
|
intercellular adhesion molecule 3 |
| chr21_-_35340759 | 2.34 |
ENST00000607953.1
|
AP000569.9
|
AP000569.9 |
| chr12_-_57871825 | 2.33 |
ENST00000548139.1
|
ARHGAP9
|
Rho GTPase activating protein 9 |
| chr17_-_61776522 | 2.33 |
ENST00000582055.1
|
LIMD2
|
LIM domain containing 2 |
| chr19_+_6887571 | 2.32 |
ENST00000250572.8
ENST00000381407.5 ENST00000312053.4 ENST00000450315.3 ENST00000381404.4 |
EMR1
|
egf-like module containing, mucin-like, hormone receptor-like 1 |
| chr3_+_46395219 | 2.29 |
ENST00000445132.2
ENST00000292301.4 |
CCR2
|
chemokine (C-C motif) receptor 2 |
| chr12_-_15082050 | 2.29 |
ENST00000540097.1
|
ERP27
|
endoplasmic reticulum protein 27 |
| chr2_+_204571198 | 2.24 |
ENST00000374481.3
ENST00000458610.2 ENST00000324106.8 |
CD28
|
CD28 molecule |
| chr10_+_129785574 | 2.24 |
ENST00000430713.2
ENST00000471218.1 |
PTPRE
|
protein tyrosine phosphatase, receptor type, E |
| chr6_-_133084564 | 2.22 |
ENST00000532012.1
|
VNN2
|
vanin 2 |
| chr13_-_99910673 | 2.22 |
ENST00000397473.2
ENST00000397470.2 |
GPR18
|
G protein-coupled receptor 18 |
| chr14_+_21423611 | 2.22 |
ENST00000304625.2
|
RNASE2
|
ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) |
| chr14_-_23299009 | 2.21 |
ENST00000488800.1
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
| chr22_+_44576770 | 2.20 |
ENST00000444313.3
ENST00000416291.1 |
PARVG
|
parvin, gamma |
| chr19_+_7741968 | 2.18 |
ENST00000597445.1
|
C19orf59
|
chromosome 19 open reading frame 59 |
| chr9_-_117150243 | 2.18 |
ENST00000374088.3
|
AKNA
|
AT-hook transcription factor |
| chr1_-_156786530 | 2.18 |
ENST00000368198.3
|
SH2D2A
|
SH2 domain containing 2A |
| chr12_-_57873329 | 2.18 |
ENST00000424809.2
|
ARHGAP9
|
Rho GTPase activating protein 9 |
| chr12_-_57873631 | 2.16 |
ENST00000393791.3
ENST00000356411.2 ENST00000552249.1 |
ARHGAP9
|
Rho GTPase activating protein 9 |
| chr1_-_156786634 | 2.16 |
ENST00000392306.2
ENST00000368199.3 |
SH2D2A
|
SH2 domain containing 2A |
| chr8_+_74903580 | 2.15 |
ENST00000284818.2
ENST00000518893.1 |
LY96
|
lymphocyte antigen 96 |
| chr15_+_74833518 | 2.14 |
ENST00000346246.5
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like) |
| chr21_-_46340884 | 2.14 |
ENST00000302347.5
ENST00000517819.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr2_+_103035102 | 2.13 |
ENST00000264260.2
|
IL18RAP
|
interleukin 18 receptor accessory protein |
| chr12_-_57871853 | 2.12 |
ENST00000549602.1
ENST00000430041.2 |
ARHGAP9
|
Rho GTPase activating protein 9 |
| chr2_+_202122703 | 2.11 |
ENST00000447616.1
ENST00000358485.4 |
CASP8
|
caspase 8, apoptosis-related cysteine peptidase |
| chr1_-_160681593 | 2.09 |
ENST00000368045.3
ENST00000368046.3 |
CD48
|
CD48 molecule |
| chr16_+_67679069 | 2.08 |
ENST00000545661.1
|
RLTPR
|
RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing |
| chrX_+_48542168 | 2.07 |
ENST00000376701.4
|
WAS
|
Wiskott-Aldrich syndrome |
| chr1_-_202129704 | 2.07 |
ENST00000476061.1
ENST00000544762.1 ENST00000467283.1 ENST00000464870.1 ENST00000435759.2 ENST00000486116.1 ENST00000543735.1 ENST00000308986.5 ENST00000477625.1 |
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7 |
| chr19_-_17958771 | 2.07 |
ENST00000534444.1
|
JAK3
|
Janus kinase 3 |
| chr1_-_32687923 | 2.07 |
ENST00000309777.6
ENST00000344461.3 ENST00000373593.1 ENST00000545122.1 |
TMEM234
|
transmembrane protein 234 |
| chr16_+_67678818 | 2.06 |
ENST00000334583.6
|
RLTPR
|
RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing |
| chr17_+_76126842 | 2.06 |
ENST00000590426.1
ENST00000590799.1 ENST00000318430.5 ENST00000589691.1 |
TMC8
|
transmembrane channel-like 8 |
| chr17_-_76124812 | 2.06 |
ENST00000592063.1
ENST00000589271.1 ENST00000322933.4 ENST00000589553.1 |
TMC6
|
transmembrane channel-like 6 |
| chr16_+_27325202 | 2.06 |
ENST00000395762.2
ENST00000562142.1 ENST00000561742.1 ENST00000543915.2 ENST00000449195.1 ENST00000380922.3 ENST00000563002.1 |
IL4R
|
interleukin 4 receptor |
| chr17_-_3819751 | 2.06 |
ENST00000225538.3
|
P2RX1
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
| chr3_+_32993065 | 2.05 |
ENST00000330953.5
|
CCR4
|
chemokine (C-C motif) receptor 4 |
| chr7_+_73624327 | 2.03 |
ENST00000361082.3
ENST00000275635.7 ENST00000470709.1 |
LAT2
|
linker for activation of T cells family, member 2 |
| chr19_+_35820064 | 2.03 |
ENST00000341773.6
ENST00000600131.1 ENST00000270311.6 ENST00000595780.1 ENST00000597916.1 ENST00000593867.1 ENST00000600424.1 ENST00000599811.1 ENST00000536635.2 ENST00000085219.5 ENST00000544992.2 ENST00000419549.2 |
CD22
|
CD22 molecule |
| chr2_-_198175495 | 2.02 |
ENST00000409153.1
ENST00000409919.1 ENST00000539527.1 |
ANKRD44
|
ankyrin repeat domain 44 |
| chr1_-_162381907 | 2.02 |
ENST00000367929.2
ENST00000359567.3 |
SH2D1B
|
SH2 domain containing 1B |
| chr17_-_43510282 | 2.01 |
ENST00000290470.3
|
ARHGAP27
|
Rho GTPase activating protein 27 |
| chr11_-_64512803 | 2.01 |
ENST00000377489.1
ENST00000354024.3 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
| chr6_-_128239749 | 2.00 |
ENST00000537166.1
|
THEMIS
|
thymocyte selection associated |
| chr1_-_202130702 | 2.00 |
ENST00000309017.3
ENST00000477554.1 ENST00000492451.1 |
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7 |
| chr2_+_204571375 | 1.99 |
ENST00000374478.4
|
CD28
|
CD28 molecule |
| chr1_-_25256368 | 1.98 |
ENST00000308873.6
|
RUNX3
|
runt-related transcription factor 3 |
| chr17_-_5522731 | 1.97 |
ENST00000576905.1
|
NLRP1
|
NLR family, pyrin domain containing 1 |
| chr8_-_134114721 | 1.96 |
ENST00000522119.1
ENST00000523610.1 ENST00000521302.1 ENST00000519558.1 ENST00000519747.1 ENST00000517648.1 |
SLA
|
Src-like-adaptor |
| chr6_-_32160622 | 1.96 |
ENST00000487761.1
ENST00000375040.3 |
GPSM3
|
G-protein signaling modulator 3 |
| chr6_-_128239685 | 1.95 |
ENST00000368250.1
|
THEMIS
|
thymocyte selection associated |
| chr19_-_17958832 | 1.95 |
ENST00000458235.1
|
JAK3
|
Janus kinase 3 |
| chr21_-_46340770 | 1.95 |
ENST00000397854.3
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr16_+_50300427 | 1.94 |
ENST00000394697.2
ENST00000566433.2 ENST00000538642.1 |
ADCY7
|
adenylate cyclase 7 |
| chr5_+_118668846 | 1.94 |
ENST00000513374.1
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8 |
| chr16_-_30393752 | 1.93 |
ENST00000566517.1
ENST00000605106.1 |
SEPT1
SEPT1
|
septin 1 Uncharacterized protein |
| chr11_-_64510409 | 1.93 |
ENST00000394429.1
ENST00000394428.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
| chr6_+_31554612 | 1.92 |
ENST00000211921.7
|
LST1
|
leukocyte specific transcript 1 |
| chr19_+_7413835 | 1.89 |
ENST00000576789.1
|
CTB-133G6.1
|
CTB-133G6.1 |
| chr11_-_64512273 | 1.88 |
ENST00000377497.3
ENST00000377487.1 ENST00000430645.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
| chr21_+_26934165 | 1.87 |
ENST00000456917.1
|
MIR155HG
|
MIR155 host gene (non-protein coding) |
| chr19_+_1077393 | 1.87 |
ENST00000590577.1
|
HMHA1
|
histocompatibility (minor) HA-1 |
| chr12_-_10588539 | 1.86 |
ENST00000381902.2
ENST00000381901.1 ENST00000539033.1 |
KLRC2
NKG2-E
|
killer cell lectin-like receptor subfamily C, member 2 Uncharacterized protein |
| chr9_-_4679419 | 1.86 |
ENST00000609131.1
ENST00000607997.1 |
RP11-6J24.6
|
RP11-6J24.6 |
| chr19_-_44285401 | 1.85 |
ENST00000262888.3
|
KCNN4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
| chr13_+_108922228 | 1.85 |
ENST00000542136.1
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b |
| chr22_+_40342819 | 1.84 |
ENST00000407075.3
|
GRAP2
|
GRB2-related adaptor protein 2 |
| chr11_+_36397915 | 1.83 |
ENST00000526682.1
ENST00000530252.1 |
PRR5L
|
proline rich 5 like |
| chr19_-_19754404 | 1.83 |
ENST00000587205.1
ENST00000445806.2 ENST00000203556.4 |
GMIP
|
GEM interacting protein |
| chr2_-_175462456 | 1.83 |
ENST00000409891.1
ENST00000410117.1 |
WIPF1
|
WAS/WASL interacting protein family, member 1 |
| chr12_+_47610315 | 1.83 |
ENST00000548348.1
ENST00000549500.1 |
PCED1B
|
PC-esterase domain containing 1B |
| chr8_-_134114866 | 1.83 |
ENST00000524345.1
|
SLA
|
Src-like-adaptor |
| chr12_+_9142131 | 1.82 |
ENST00000356986.3
ENST00000266551.4 |
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1 |
| chr19_-_19754354 | 1.82 |
ENST00000587238.1
|
GMIP
|
GEM interacting protein |
| chr14_+_105953246 | 1.81 |
ENST00000392531.3
|
CRIP1
|
cysteine-rich protein 1 (intestinal) |
| chr2_-_99388543 | 1.81 |
ENST00000419865.2
|
AC109826.1
|
AC109826.1 |
| chr14_-_24809154 | 1.81 |
ENST00000216274.5
|
RIPK3
|
receptor-interacting serine-threonine kinase 3 |
| chr14_+_105953204 | 1.80 |
ENST00000409393.2
|
CRIP1
|
cysteine-rich protein 1 (intestinal) |
| chr22_-_24181174 | 1.80 |
ENST00000318109.7
ENST00000406855.3 ENST00000404056.1 ENST00000476077.1 |
DERL3
|
derlin 3 |
| chr17_-_6983550 | 1.80 |
ENST00000576617.1
ENST00000416562.2 |
CLEC10A
|
C-type lectin domain family 10, member A |
| chr9_+_214842 | 1.79 |
ENST00000453981.1
ENST00000432829.2 |
DOCK8
|
dedicator of cytokinesis 8 |
| chr14_+_22564294 | 1.79 |
ENST00000390452.2
|
TRDV1
|
T cell receptor delta variable 1 |
| chr19_-_52255107 | 1.79 |
ENST00000595042.1
ENST00000304748.4 |
FPR1
|
formyl peptide receptor 1 |
| chr17_-_3867585 | 1.77 |
ENST00000359983.3
ENST00000352011.3 ENST00000397043.3 ENST00000397041.3 ENST00000397035.3 ENST00000397039.1 ENST00000309890.7 |
ATP2A3
|
ATPase, Ca++ transporting, ubiquitous |
Network of associatons between targets according to the STRING database.
First level regulatory network of FLI1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 8.5 | GO:0039650 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 1.6 | 7.8 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 1.4 | 12.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 1.3 | 4.0 | GO:0045210 | negative regulation of dendritic cell cytokine production(GO:0002731) FasL biosynthetic process(GO:0045210) |
| 1.3 | 4.0 | GO:2000451 | astrocyte chemotaxis(GO:0035700) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) positive regulation of T cell extravasation(GO:2000409) positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) regulation of astrocyte chemotaxis(GO:2000458) |
| 1.1 | 3.3 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 1.1 | 3.3 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 1.1 | 3.2 | GO:0061485 | memory T cell proliferation(GO:0061485) |
| 1.0 | 3.1 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
| 1.0 | 3.0 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 1.0 | 3.8 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 0.9 | 1.8 | GO:0035698 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.9 | 5.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.9 | 18.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.9 | 2.6 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.8 | 2.5 | GO:0045553 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.8 | 6.5 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.8 | 14.5 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.7 | 1.5 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 0.7 | 3.6 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.7 | 0.7 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 0.7 | 2.6 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 0.7 | 1.3 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
| 0.7 | 2.0 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.6 | 12.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.6 | 4.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.6 | 7.1 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
| 0.6 | 2.4 | GO:0043375 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.6 | 12.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.6 | 4.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.6 | 1.7 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.5 | 1.6 | GO:1900081 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 0.5 | 2.7 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.5 | 1.6 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.5 | 0.5 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.5 | 2.1 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
| 0.5 | 1.0 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
| 0.5 | 2.1 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.5 | 2.5 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.5 | 1.5 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
| 0.5 | 2.4 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.5 | 2.8 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.4 | 3.1 | GO:0048619 | embryonic genitalia morphogenesis(GO:0030538) embryonic hindgut morphogenesis(GO:0048619) |
| 0.4 | 1.3 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 0.4 | 3.0 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.4 | 2.1 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.4 | 2.1 | GO:0002554 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 0.4 | 1.2 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.4 | 5.3 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.4 | 2.0 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
| 0.4 | 1.6 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
| 0.4 | 3.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.4 | 1.6 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.4 | 3.9 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.4 | 1.1 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.4 | 7.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.4 | 2.2 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.4 | 0.7 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.4 | 1.4 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.4 | 5.0 | GO:0043383 | negative T cell selection(GO:0043383) |
| 0.4 | 1.4 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.3 | 0.3 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.3 | 2.4 | GO:2000769 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
| 0.3 | 2.4 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.3 | 0.7 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.3 | 1.0 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.3 | 4.0 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.3 | 1.3 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.3 | 2.6 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.3 | 1.0 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.3 | 1.0 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.3 | 2.2 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.3 | 6.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.3 | 2.2 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.3 | 1.2 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
| 0.3 | 0.9 | GO:0098939 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.3 | 1.9 | GO:2000538 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 0.3 | 0.6 | GO:0032765 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) positive regulation of mast cell cytokine production(GO:0032765) |
| 0.3 | 1.5 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.3 | 1.5 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.3 | 3.9 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.3 | 0.9 | GO:1900098 | epithelial cell differentiation involved in salivary gland development(GO:0060690) epithelial cell maturation involved in salivary gland development(GO:0060691) regulation of plasma cell differentiation(GO:1900098) positive regulation of plasma cell differentiation(GO:1900100) positive regulation of lactation(GO:1903489) |
| 0.3 | 1.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.3 | 2.7 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.3 | 0.9 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) gall bladder development(GO:0061010) |
| 0.3 | 1.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.3 | 1.4 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.3 | 1.7 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.3 | 5.8 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
| 0.3 | 0.8 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.3 | 4.6 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.3 | 1.4 | GO:0032252 | secretory granule localization(GO:0032252) |
| 0.3 | 21.9 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.3 | 0.5 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
| 0.3 | 0.8 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.3 | 1.0 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.3 | 4.1 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.3 | 2.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.3 | 0.8 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.3 | 1.5 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
| 0.3 | 0.8 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 0.3 | 1.3 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.3 | 0.8 | GO:0033319 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.3 | 3.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.2 | 1.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.2 | 1.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.2 | 1.7 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.2 | 2.7 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.2 | 2.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.2 | 3.1 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
| 0.2 | 5.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.2 | 0.7 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.2 | 0.9 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.2 | 1.8 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.2 | 0.5 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.2 | 4.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.2 | 1.1 | GO:1904868 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.2 | 0.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 | 0.4 | GO:0034756 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
| 0.2 | 1.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.2 | 4.6 | GO:0002467 | germinal center formation(GO:0002467) |
| 0.2 | 0.9 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.2 | 1.3 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.2 | 3.9 | GO:0008228 | opsonization(GO:0008228) |
| 0.2 | 1.5 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.2 | 1.5 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.2 | 22.2 | GO:0042100 | B cell proliferation(GO:0042100) |
| 0.2 | 14.9 | GO:0002279 | mast cell activation involved in immune response(GO:0002279) mast cell degranulation(GO:0043303) |
| 0.2 | 0.8 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.2 | 2.9 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.2 | 2.1 | GO:0002507 | tolerance induction(GO:0002507) |
| 0.2 | 0.8 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.2 | 3.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.2 | 22.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.2 | 2.2 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.2 | 0.6 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 | 0.8 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 0.2 | 5.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.2 | 13.2 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 0.2 | 6.5 | GO:0010447 | response to acidic pH(GO:0010447) |
| 0.2 | 1.1 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.2 | 0.5 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.2 | 0.2 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.2 | 0.7 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.2 | 1.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.2 | 1.9 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.2 | 10.8 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.2 | 1.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.2 | 0.7 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.2 | 3.5 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.2 | 1.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.2 | 1.3 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.2 | 0.9 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.2 | 1.9 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 | 0.5 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
| 0.2 | 1.9 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.2 | 1.8 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.2 | 1.1 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.2 | 3.6 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
| 0.2 | 2.6 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.2 | 0.3 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
| 0.2 | 1.8 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 0.4 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.1 | 1.0 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.1 | 1.1 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.1 | 1.3 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.1 | 0.4 | GO:1904586 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
| 0.1 | 2.9 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 | 0.3 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.1 | 2.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.1 | 0.5 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
| 0.1 | 0.4 | GO:0051685 | endoplasmic reticulum localization(GO:0051643) maintenance of ER location(GO:0051685) |
| 0.1 | 0.8 | GO:0044782 | cilium organization(GO:0044782) |
| 0.1 | 0.7 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 | 0.7 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.1 | 2.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 | 0.3 | GO:0070142 | synaptic vesicle budding(GO:0070142) lysosomal membrane organization(GO:0097212) |
| 0.1 | 1.0 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.1 | 0.4 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.1 | 3.1 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.1 | 1.0 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
| 0.1 | 0.3 | GO:0090427 | activation of meiosis(GO:0090427) |
| 0.1 | 1.4 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.1 | 1.3 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 | 16.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.1 | 0.8 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.1 | 1.1 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.1 | 2.6 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.1 | 0.7 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.1 | 1.2 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.1 | 2.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
| 0.1 | 0.8 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 | 2.8 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.1 | 4.6 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.1 | 0.5 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.1 | 18.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 | 0.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 | 0.9 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 | 3.1 | GO:0045576 | mast cell activation(GO:0045576) |
| 0.1 | 0.3 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
| 0.1 | 0.4 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.1 | 5.4 | GO:1900077 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.1 | 0.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.1 | 1.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.1 | 0.9 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 | 0.3 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) ITP metabolic process(GO:0046041) |
| 0.1 | 0.1 | GO:0018307 | enzyme active site formation(GO:0018307) |
| 0.1 | 1.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.1 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.1 | 1.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 | 0.2 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
| 0.1 | 1.2 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.1 | 2.8 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.1 | 0.2 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
| 0.1 | 0.9 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.1 | 1.7 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
| 0.1 | 0.9 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.1 | 0.5 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.1 | 0.7 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
| 0.1 | 0.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.1 | 2.9 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.1 | 0.2 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
| 0.1 | 2.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.1 | 0.7 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.1 | 0.9 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.1 | 0.5 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.1 | 1.0 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 0.1 | 0.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.1 | 0.5 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.1 | 0.7 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 | 2.4 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.1 | 0.9 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.1 | 7.8 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.1 | 0.3 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 0.1 | 1.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 | 0.5 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 0.1 | 0.7 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.1 | 0.5 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.1 | 1.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 | 0.2 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.1 | 0.3 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 | 0.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.1 | 0.2 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.1 | 0.4 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.1 | 1.6 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.1 | 0.1 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) skeletal muscle satellite cell activation(GO:0014719) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.1 | 0.9 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
| 0.1 | 0.2 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.1 | 0.8 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.1 | 1.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.1 | 0.4 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
| 0.1 | 2.1 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.1 | 0.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 | 0.4 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.1 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.1 | 0.6 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.1 | 0.3 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.1 | 0.4 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.1 | 0.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.1 | 0.7 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 | 0.2 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.1 | 0.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.1 | 0.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.1 | 1.7 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.1 | 1.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.1 | 0.4 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.1 | 0.3 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
| 0.1 | 0.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 | 0.5 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.1 | 4.4 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
| 0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.3 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.1 | 0.5 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
| 0.1 | 0.3 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 0.1 | 0.3 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 0.1 | 0.9 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.1 | 0.3 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.1 | 1.0 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.1 | 0.8 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.1 | 0.6 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 0.1 | 0.7 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 | 0.1 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.1 | 0.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.1 | 0.6 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.1 | 2.1 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.1 | 0.1 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) histone H3-K9 deacetylation(GO:1990619) |
| 0.1 | 0.3 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.1 | 0.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.1 | 0.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 | 0.3 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.1 | 0.4 | GO:0021764 | amygdala development(GO:0021764) |
| 0.1 | 0.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.1 | 0.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.1 | 0.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 0.1 | 0.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.1 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 | 0.3 | GO:0051622 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 0.1 | 0.1 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.1 | 0.6 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 0.2 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.1 | 1.1 | GO:0032526 | response to retinoic acid(GO:0032526) |
| 0.1 | 3.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.1 | 1.7 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.1 | 0.6 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.1 | 0.2 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 0.1 | 4.7 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
| 0.1 | 0.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.1 | 0.3 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.1 | 0.7 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.1 | 1.5 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 | 0.9 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 0.1 | 0.4 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
| 0.0 | 0.1 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
| 0.0 | 1.0 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
| 0.0 | 0.8 | GO:0015866 | ADP transport(GO:0015866) |
| 0.0 | 0.4 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 | 0.6 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.0 | 1.5 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.0 | 0.6 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
| 0.0 | 0.2 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
| 0.0 | 0.8 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 | 0.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.0 | 0.5 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.0 | 1.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.0 | 0.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.0 | 0.6 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.0 | 0.4 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.0 | 0.4 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.0 | 0.4 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
| 0.0 | 1.8 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.0 | 0.4 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.0 | 0.5 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
| 0.0 | 0.6 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.0 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.0 | 1.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.0 | 0.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.0 | 0.3 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.0 | 0.2 | GO:0075713 | establishment of integrated proviral latency(GO:0075713) |
| 0.0 | 1.8 | GO:0042116 | macrophage activation(GO:0042116) |
| 0.0 | 0.2 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.0 | 0.4 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.0 | 0.3 | GO:1902074 | response to salt(GO:1902074) |
| 0.0 | 2.6 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 | 0.1 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 0.0 | 0.9 | GO:0050848 | regulation of calcium-mediated signaling(GO:0050848) |
| 0.0 | 0.3 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.0 | 1.2 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.0 | 1.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.0 | 0.8 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.0 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.0 | 0.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.0 | 0.2 | GO:0002003 | angiotensin maturation(GO:0002003) |
| 0.0 | 1.0 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.0 | 0.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.0 | 0.2 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.0 | 3.4 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.0 | 0.4 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
| 0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.0 | 1.3 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.0 | 1.0 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 0.0 | 0.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.0 | 0.1 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
| 0.0 | 0.3 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.0 | 25.9 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
| 0.0 | 0.2 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) |
| 0.0 | 0.7 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.0 | 0.3 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.0 | 1.0 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
| 0.0 | 0.1 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.0 | 3.3 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
| 0.0 | 0.3 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.0 | 0.4 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
| 0.0 | 0.8 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 0.0 | 0.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 | 2.0 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.0 | 2.0 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.0 | 0.1 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.0 | 1.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.0 | 0.3 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.0 | 1.0 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
| 0.0 | 0.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.0 | 0.6 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.0 | 2.0 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.0 | 0.1 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.0 | 0.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.0 | 0.8 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 | 0.5 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.0 | 1.2 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
| 0.0 | 5.0 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
| 0.0 | 0.9 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
| 0.0 | 0.9 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 | 0.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 0.0 | 0.6 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
| 0.0 | 1.0 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.0 | 0.6 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
| 0.0 | 0.2 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.0 | 0.4 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.0 | 0.4 | GO:0018212 | peptidyl-tyrosine phosphorylation(GO:0018108) peptidyl-tyrosine modification(GO:0018212) |
| 0.0 | 1.4 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.0 | 0.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 | 3.2 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
| 0.0 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.0 | 0.3 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 0.0 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 | 0.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.0 | 0.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.0 | 0.1 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.0 | 0.9 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.0 | 0.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.0 | 0.1 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.0 | 0.4 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.0 | 0.4 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
| 0.0 | 0.2 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.0 | 0.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.0 | 0.2 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.0 | 0.6 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.0 | 0.0 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
| 0.0 | 0.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.0 | 0.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.0 | 0.1 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.0 | 0.1 | GO:0007135 | meiosis II(GO:0007135) |
| 0.0 | 1.3 | GO:0070206 | protein trimerization(GO:0070206) |
| 0.0 | 0.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
| 0.0 | 0.3 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.0 | 0.0 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.0 | 0.0 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
| 0.0 | 0.0 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
| 0.0 | 0.1 | GO:0033668 | suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) negative regulation by symbiont of host programmed cell death(GO:0052041) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 0.0 | 0.9 | GO:0031497 | chromatin assembly(GO:0031497) |
| 0.0 | 0.6 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.0 | 0.8 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.0 | 0.6 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.0 | 0.8 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 | 0.3 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
| 0.0 | 0.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 | 0.2 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
| 0.0 | 0.4 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
| 0.0 | 0.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 | 0.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.0 | 3.1 | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043122) |
| 0.0 | 0.2 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 | 0.6 | GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition(GO:0051437) |
| 0.0 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.0 | 0.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.0 | 0.3 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.0 | 1.0 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
| 0.0 | 0.5 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.0 | 0.6 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 | 0.9 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
| 0.0 | 0.1 | GO:1901985 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
| 0.0 | 3.0 | GO:0008360 | regulation of cell shape(GO:0008360) |
| 0.0 | 0.2 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
| 0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.0 | 0.1 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 0.0 | 0.2 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.0 | 0.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.0 | 0.1 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.0 | 0.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.0 | 0.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 | 0.1 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
| 0.0 | 0.7 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 | 0.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
| 0.0 | 0.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
| 0.0 | 0.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
| 0.0 | 0.5 | GO:0046039 | GTP metabolic process(GO:0046039) |
| 0.0 | 1.0 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 0.2 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
| 0.0 | 0.1 | GO:0036344 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
| 0.0 | 1.2 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 0.0 | 0.7 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.0 | 0.1 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.0 | 0.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.0 | 0.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.0 | 0.4 | GO:0016577 | histone demethylation(GO:0016577) |
| 0.0 | 1.2 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
| 0.0 | 0.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.0 | 0.9 | GO:0051291 | protein heterooligomerization(GO:0051291) |
| 0.0 | 0.2 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 | 7.5 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
| 0.0 | 0.2 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.0 | 0.1 | GO:2000345 | regulation of hepatocyte proliferation(GO:2000345) negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.0 | 0.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 | 0.1 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
| 0.0 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.0 | 1.6 | GO:0006413 | translational initiation(GO:0006413) |
| 0.0 | 0.5 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.0 | 0.2 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
| 0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
| 0.0 | 0.1 | GO:0043634 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.0 | 0.5 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.0 | 0.4 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
| 0.0 | 0.4 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
| 0.0 | 0.3 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.0 | 0.2 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 | 0.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.0 | 0.2 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
| 0.0 | 0.1 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.0 | 0.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.0 | 0.3 | GO:0006298 | mismatch repair(GO:0006298) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 15.7 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 1.3 | 9.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.8 | 7.3 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.8 | 29.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.7 | 42.4 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.5 | 2.7 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.5 | 13.2 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.5 | 2.8 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.4 | 1.3 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
| 0.4 | 2.2 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.4 | 1.3 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.4 | 1.5 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
| 0.4 | 8.8 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.4 | 1.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.4 | 10.0 | GO:0042599 | lamellar body(GO:0042599) |
| 0.3 | 2.7 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.3 | 1.4 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.3 | 0.3 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
| 0.3 | 17.8 | GO:0019814 | immunoglobulin complex(GO:0019814) |
| 0.3 | 2.1 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.3 | 0.9 | GO:0032783 | ELL-EAF complex(GO:0032783) |
| 0.3 | 7.9 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.3 | 7.3 | GO:0061702 | inflammasome complex(GO:0061702) |
| 0.3 | 2.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.3 | 1.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.3 | 1.8 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.3 | 1.0 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 0.3 | 1.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.3 | 1.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.2 | 0.8 | GO:0031523 | Myb complex(GO:0031523) |
| 0.2 | 0.2 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.2 | 3.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.2 | 1.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.2 | 1.1 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.2 | 1.4 | GO:0031415 | NatA complex(GO:0031415) |
| 0.2 | 1.7 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.2 | 5.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.2 | 1.1 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.2 | 3.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.1 | 2.1 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.1 | 1.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.1 | 1.3 | GO:0032009 | early phagosome(GO:0032009) |
| 0.1 | 0.6 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.1 | 1.0 | GO:0089701 | U2AF(GO:0089701) |
| 0.1 | 1.1 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.1 | 1.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 1.5 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.1 | 0.9 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.1 | 3.6 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.1 | 2.5 | GO:0032059 | bleb(GO:0032059) |
| 0.1 | 0.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.1 | 1.3 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.1 | 0.3 | GO:0009346 | citrate lyase complex(GO:0009346) |
| 0.1 | 0.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.1 | 28.0 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.1 | 1.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.1 | 1.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.1 | 0.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.1 | 0.3 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.1 | 0.4 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 0.1 | 39.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.1 | 2.0 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.1 | 1.7 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.1 | 2.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.1 | 1.0 | GO:0051286 | cell tip(GO:0051286) |
| 0.1 | 2.5 | GO:0001726 | ruffle(GO:0001726) |
| 0.1 | 1.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.1 | 0.7 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.1 | 1.9 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.1 | 13.2 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.1 | 0.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.1 | 7.4 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 9.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 0.2 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.1 | 0.7 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.1 | 2.0 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.1 | 2.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.1 | 4.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 1.9 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.1 | 0.9 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.1 | 0.5 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.1 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.1 | 0.2 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.1 | 0.7 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.1 | 3.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.1 | 1.0 | GO:0030478 | actin cap(GO:0030478) |
| 0.1 | 5.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.1 | 0.7 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.1 | 0.4 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.1 | 0.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.1 | 0.8 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.1 | 5.4 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.1 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.1 | 0.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.1 | 0.4 | GO:0098536 | deuterosome(GO:0098536) |
| 0.1 | 0.4 | GO:1990462 | omegasome(GO:1990462) |
| 0.1 | 0.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.1 | 0.4 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.1 | 3.0 | GO:0031252 | cell leading edge(GO:0031252) |
| 0.1 | 0.3 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.1 | 0.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 0.8 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.1 | 10.1 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.1 | 0.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.1 | 0.4 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.0 | 0.9 | GO:0097227 | sperm annulus(GO:0097227) |
| 0.0 | 0.4 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.0 | 0.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.0 | 4.8 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.0 | 1.2 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.0 | 0.6 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.0 | 0.8 | GO:0097433 | dense body(GO:0097433) |
| 0.0 | 0.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.0 | 0.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.0 | 0.3 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.0 | 0.1 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.0 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.0 | 0.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.0 | 0.2 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
| 0.0 | 0.4 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.0 | 18.5 | GO:0034774 | secretory granule lumen(GO:0034774) |
| 0.0 | 1.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.0 | 0.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.0 | 0.8 | GO:0015629 | actin cytoskeleton(GO:0015629) |
| 0.0 | 1.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.0 | 0.1 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.0 | 0.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.0 | 1.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.0 | 0.2 | GO:0005797 | Golgi trans cisterna(GO:0000138) Golgi medial cisterna(GO:0005797) |
| 0.0 | 0.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.0 | 0.5 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.0 | 0.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.0 | 0.7 | GO:0046930 | pore complex(GO:0046930) |
| 0.0 | 0.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.0 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.0 | 2.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.0 | 0.6 | GO:0031105 | septin complex(GO:0031105) |
| 0.0 | 3.9 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.0 | 0.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.0 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.0 | 0.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.0 | 1.0 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.0 | 0.3 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.0 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
| 0.0 | 0.5 | GO:0010369 | chromocenter(GO:0010369) |
| 0.0 | 4.6 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 3.0 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 0.2 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.0 | 0.3 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
| 0.0 | 0.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.0 | 3.7 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 0.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.0 | 0.1 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.0 | 1.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 1.1 | GO:1990391 | DNA repair complex(GO:1990391) |
| 0.0 | 1.7 | GO:0030175 | filopodium(GO:0030175) |
| 0.0 | 0.4 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.0 | 3.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
| 0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.0 | 1.1 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.0 | 0.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.0 | 1.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.0 | 0.1 | GO:0043203 | axon hillock(GO:0043203) |
| 0.0 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.0 | 0.2 | GO:0031906 | late endosome lumen(GO:0031906) |
| 0.0 | 0.1 | GO:0008091 | spectrin(GO:0008091) |
| 0.0 | 0.5 | GO:0030904 | retromer complex(GO:0030904) |
| 0.0 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.0 | 9.8 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.0 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.0 | 4.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 0.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.0 | 1.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 0.1 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.0 | 2.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.7 | GO:0044815 | DNA packaging complex(GO:0044815) |
| 0.0 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.0 | 0.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.0 | 1.9 | GO:0005884 | actin filament(GO:0005884) |
| 0.0 | 1.6 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
| 0.0 | 0.0 | GO:0034464 | BBSome(GO:0034464) |
| 0.0 | 0.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 0.1 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.0 | 1.4 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.0 | 0.1 | GO:0097441 | basilar dendrite(GO:0097441) |
| 0.0 | 3.7 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.0 | 0.4 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.0 | 0.1 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 1.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 2.3 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.0 | 20.8 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 2.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.0 | 0.0 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.0 | 0.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.0 | 3.6 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.0 | 8.1 | GO:0000139 | Golgi membrane(GO:0000139) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 18.4 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 1.5 | 6.0 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
| 1.5 | 10.2 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 1.4 | 8.6 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
| 1.3 | 15.7 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 1.1 | 7.8 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 1.1 | 3.2 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 1.0 | 2.1 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 0.9 | 5.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.8 | 2.4 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 0.8 | 4.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.8 | 4.7 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.7 | 3.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.7 | 2.8 | GO:0019862 | IgA binding(GO:0019862) |
| 0.7 | 4.1 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.6 | 0.6 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.6 | 2.9 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.5 | 1.6 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 0.5 | 16.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.5 | 7.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.5 | 1.5 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
| 0.5 | 11.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.5 | 2.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.5 | 2.8 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.4 | 1.3 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 0.4 | 1.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.4 | 3.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.4 | 1.1 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
| 0.4 | 1.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) interleukin-3 receptor binding(GO:0005135) |
| 0.4 | 1.1 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
| 0.4 | 3.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.3 | 7.2 | GO:0005522 | profilin binding(GO:0005522) |
| 0.3 | 2.2 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.3 | 0.9 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.3 | 15.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.3 | 1.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.3 | 1.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.3 | 1.5 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
| 0.3 | 1.8 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.3 | 2.4 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.3 | 2.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.3 | 6.0 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.3 | 2.1 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.3 | 18.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.3 | 1.7 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 0.3 | 3.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.3 | 2.6 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.3 | 0.8 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.3 | 1.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
| 0.3 | 0.8 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 0.3 | 1.0 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 0.3 | 0.8 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) follicle-stimulating hormone receptor binding(GO:0031762) platelet activating factor receptor binding(GO:0031859) |
| 0.3 | 0.8 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.3 | 1.0 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
| 0.3 | 1.5 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
| 0.3 | 1.3 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.3 | 0.8 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
| 0.3 | 4.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.2 | 1.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.2 | 3.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.2 | 2.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.2 | 1.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.2 | 1.7 | GO:0042806 | fucose binding(GO:0042806) |
| 0.2 | 0.7 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 0.2 | 0.9 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
| 0.2 | 0.9 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.2 | 1.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.2 | 7.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.2 | 2.3 | GO:0019863 | IgE binding(GO:0019863) |
| 0.2 | 1.4 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.2 | 1.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.2 | 0.7 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 0.2 | 1.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.2 | 1.3 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.2 | 2.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.2 | 15.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.2 | 19.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.2 | 1.7 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.2 | 1.4 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.2 | 8.3 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.2 | 39.0 | GO:0003823 | antigen binding(GO:0003823) |
| 0.2 | 1.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.2 | 1.7 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.2 | 2.3 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.2 | 1.9 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.2 | 0.9 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.2 | 0.9 | GO:0005124 | N-formyl peptide receptor activity(GO:0004982) scavenger receptor binding(GO:0005124) |
| 0.2 | 0.4 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.2 | 4.2 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.2 | 5.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.2 | 5.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.2 | 21.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.2 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.2 | 5.6 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.2 | 0.8 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.2 | 1.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.2 | 0.8 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.2 | 2.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.1 | 5.0 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.1 | 2.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.1 | 6.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 1.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.1 | 2.7 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.1 | 2.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.1 | 4.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 4.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 0.7 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.1 | 0.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.1 | 1.6 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.1 | 6.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 1.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.1 | 1.6 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.1 | 0.4 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.1 | 0.2 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 0.1 | 0.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.1 | 1.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.1 | 3.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.1 | 1.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.1 | 0.5 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.1 | 0.9 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.1 | 0.3 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.1 | 2.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.1 | 0.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.1 | 0.4 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) copper-dependent protein binding(GO:0032767) |
| 0.1 | 4.5 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.1 | 0.9 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.1 | 0.3 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.1 | 1.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 0.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.1 | 0.7 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.1 | 0.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.1 | 0.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.1 | 0.3 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
| 0.1 | 2.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.1 | 0.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.1 | 0.8 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.1 | 3.6 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 0.9 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.1 | 2.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.1 | 5.4 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 0.8 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.1 | 0.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.1 | 0.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.1 | 0.4 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.1 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
| 0.1 | 0.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.1 | 0.3 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.1 | 0.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 1.0 | GO:0003713 | transcription coactivator activity(GO:0003713) |
| 0.1 | 1.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.1 | 1.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.1 | 0.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.1 | 0.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.1 | 0.2 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 0.1 | 1.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.1 | 1.9 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.1 | 0.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.1 | 1.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.1 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.1 | 0.5 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.1 | 1.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.1 | 2.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.1 | 0.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.1 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.1 | 0.6 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.1 | 2.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.1 | 0.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.1 | 0.5 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
| 0.1 | 0.3 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.1 | 0.6 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.1 | 0.2 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.1 | 1.4 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.1 | 0.8 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.1 | 1.2 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.1 | 0.1 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 0.1 | 1.4 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.1 | 0.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.1 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.1 | 1.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.1 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.1 | 6.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 0.3 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.1 | 0.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.1 | 0.4 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.1 | 26.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.1 | 1.8 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.1 | 3.3 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.1 | 1.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.1 | 1.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.1 | 0.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.0 | 0.8 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.0 | 1.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.0 | 0.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.0 | 0.2 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.0 | 1.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 1.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.0 | 3.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.0 | 1.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.0 | 1.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.0 | 1.6 | GO:0015026 | coreceptor activity(GO:0015026) |
| 0.0 | 0.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.0 | 0.1 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.0 | 0.3 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.0 | 0.1 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 0.0 | 0.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.0 | 0.4 | GO:0050544 | arachidonic acid binding(GO:0050544) |
| 0.0 | 0.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.0 | 0.4 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.0 | 0.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.0 | 0.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.0 | 0.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.0 | 2.5 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
| 0.0 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.0 | 0.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.0 | 0.4 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
| 0.0 | 1.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.0 | 0.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 0.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.0 | 0.1 | GO:0031386 | protein tag(GO:0031386) |
| 0.0 | 0.3 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.0 | 0.2 | GO:0016896 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
| 0.0 | 0.2 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 0.0 | 0.9 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.0 | 0.7 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 0.3 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.0 | 6.3 | GO:0005178 | integrin binding(GO:0005178) |
| 0.0 | 0.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.0 | 1.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.0 | 0.1 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 0.0 | 0.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.0 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.0 | 19.2 | GO:0032561 | guanyl ribonucleotide binding(GO:0032561) |
| 0.0 | 0.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.0 | 0.7 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.0 | 0.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.0 | 0.1 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 0.0 | 1.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.0 | 3.0 | GO:0005518 | collagen binding(GO:0005518) |
| 0.0 | 0.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 0.0 | 0.2 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.0 | 0.6 | GO:0001083 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.0 | 0.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.0 | 0.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.0 | 0.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.0 | 0.3 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.0 | 1.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.0 | 0.8 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.0 | 11.1 | GO:0030246 | carbohydrate binding(GO:0030246) |
| 0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.0 | 0.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.0 | 0.9 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.0 | 0.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.0 | 0.2 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.0 | 0.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.0 | 6.0 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.0 | 0.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.0 | 0.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.0 | 0.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.0 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 0.0 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 0.0 | 0.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.0 | 0.2 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.0 | 0.7 | GO:0022829 | wide pore channel activity(GO:0022829) |
| 0.0 | 0.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.0 | 7.6 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.0 | 0.2 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.0 | 1.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.0 | 1.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.0 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.0 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.0 | 0.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.0 | 0.1 | GO:0042356 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
| 0.0 | 1.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.1 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.0 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.0 | 0.2 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
| 0.0 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.0 | 0.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.0 | 1.2 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.0 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.0 | 0.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.0 | 1.1 | GO:0019955 | cytokine binding(GO:0019955) |
| 0.0 | 0.5 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 0.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.0 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
| 0.0 | 0.1 | GO:0004386 | helicase activity(GO:0004386) |
| 0.0 | 0.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.0 | 0.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.0 | 0.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.0 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.0 | 0.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 0.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.0 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.0 | 0.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.6 | 69.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.4 | 14.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.3 | 20.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.3 | 7.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.3 | 5.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.3 | 4.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.3 | 9.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.3 | 10.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.2 | 2.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.2 | 13.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.2 | 2.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.2 | 15.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.2 | 7.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.2 | 5.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.2 | 3.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.2 | 2.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.2 | 7.7 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 16.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 4.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.1 | 6.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.1 | 6.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.1 | 5.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.1 | 3.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.1 | 2.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.1 | 4.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 2.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.1 | 7.1 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.1 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.1 | 1.7 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.1 | 4.0 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.1 | 1.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.1 | 1.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.1 | 1.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 1.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 6.9 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 0.8 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.1 | 1.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 15.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 1.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 25.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 0.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.0 | 7.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.0 | 2.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.0 | 3.9 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.0 | 1.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 0.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.0 | 2.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 0.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.0 | 1.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.0 | 0.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.0 | 2.2 | PID ATM PATHWAY | ATM pathway |
| 0.0 | 1.1 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.0 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 0.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.0 | 1.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 0.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.0 | 1.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.0 | 0.5 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.0 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.0 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 0.0 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.0 | 0.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.0 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.0 | 1.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 0.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.0 | 0.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.0 | 0.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.0 | 0.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.0 | 0.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.0 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 1.0 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.0 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 0.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 0.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.0 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 0.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.0 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.0 | 0.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.0 | 1.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.0 | 0.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 0.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.0 | 0.6 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 0.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.0 | 27.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.6 | 2.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.5 | 18.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.5 | 11.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.4 | 10.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.4 | 8.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.4 | 16.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.4 | 1.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.4 | 42.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.3 | 12.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.3 | 4.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.3 | 7.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.3 | 10.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.3 | 5.8 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.2 | 2.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.2 | 1.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.2 | 1.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.2 | 1.9 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.2 | 1.3 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
| 0.2 | 1.7 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.2 | 4.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.2 | 11.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.1 | 6.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.1 | 2.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.1 | 1.9 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
| 0.1 | 3.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 2.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.1 | 3.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.1 | 4.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 0.1 | 8.0 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.1 | 2.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.1 | 18.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.1 | 6.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.1 | 0.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.1 | 1.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.1 | 0.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.1 | 1.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.1 | 4.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.1 | 1.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.1 | 0.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.1 | 4.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.1 | 17.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.1 | 1.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.1 | 2.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.1 | 22.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 1.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.1 | 5.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.1 | 1.2 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.1 | 2.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 0.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.1 | 6.0 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.1 | 1.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.1 | 0.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.0 | 3.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.0 | 0.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.0 | 2.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.0 | 1.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.0 | 0.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.0 | 0.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.0 | 0.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.0 | 1.6 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
| 0.0 | 2.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.0 | 1.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.0 | 2.1 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
| 0.0 | 0.7 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.0 | 2.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.0 | 1.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.0 | 1.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.0 | 1.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.0 | 1.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.0 | 1.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.0 | 0.6 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 0.0 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.0 | 1.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.0 | 0.6 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 0.0 | 1.6 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
| 0.0 | 2.7 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.0 | 2.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 2.2 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
| 0.0 | 2.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 1.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 1.1 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.0 | 1.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 0.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.0 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.0 | 1.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.0 | 0.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.0 | 0.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.0 | 3.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.0 | 0.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.0 | 0.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.0 | 0.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.0 | 0.0 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
| 0.0 | 0.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.0 | 1.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.0 | 0.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 0.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |